Symphony Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,788
Closed -$320K 361
2017
Q4
$320K Sell
3,788
-4,335
-53% -$369K 0.03% 314
2017
Q3
$695K Sell
8,123
-60
-0.7% -$4.92K 0.08% 224
2017
Q2
$674K Sell
8,183
-399
-5% -$32.6K 0.08% 227
2017
Q1
$722K Sell
8,582
-282
-3% -$22.6K 0.07% 239
2016
Q4
$652K Sell
8,864
-2,682
-23% -$200K 0.07% 251
2016
Q3
$927K Sell
11,546
-617
-5% -$49.4K 0.09% 201
2016
Q2
$958K Sell
12,163
-628
-5% -$47.3K 0.1% 183
2016
Q1
$921K Sell
12,791
-340
-3% -$25.7K 0.1% 197
2015
Q4
$1.11M Buy
13,131
+4,126
+46% +$342K 0.12% 178
2015
Q3
$753K Buy
+9,005
New +$760K 0.09% 241
2013
Q4
Sell
-16,843
Closed -$847K 480
2013
Q3
$847K Sell
16,843
-2,765
-14% -$145K 0.09% 216
2013
Q2
$963K Buy
+19,608
New +$1.07M 0.09% 201

Other funds holding LLY

Symphony Asset Management's LLY Position: Q1 2018 in Review

Symphony Asset Management sold out of Eli Lilly (LLY) in Q1 2018, closing a stake of 3,788 shares — an estimated $320K sold.

Symphony Asset Management first reported a position in LLY in Q2 2013 and held it in 12 quarters. The position peaked at $1.11M in Q4 2015. 1,333 funds tracked by Wall St. Rank hold LLY as of Q1 2018.

  • Symphony Asset Management reported no remaining Eli Lilly position as of Q1 2018 after selling out during the quarter.
  • Symphony Asset Management sold 3,788 Eli Lilly shares in Q1 2018, an estimated $320K.
  • Symphony Asset Management first reported a position in Eli Lilly in Q2 2013 and held it in 12 quarters.
  • Symphony Asset Management's Eli Lilly position peaked at $1.11M in Q4 2015.
  • 1,333 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2018.

Based on Symphony Asset Management's 13F filing for Q1 2018, filed 11 May 2018.